CBLL

Ceribell, Inc.

Nasdaq · Electromedical & Electrotherapeutic Apparatus

Insider trades

Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

Ceribell makes a point-of-care EEG device that uses AI-based analysis to help clinicians rapidly detect seizures at the bedside, primarily in emergency rooms and ICUs, without requiring a neurologist or EEG technician on-site.

Industry

Electromedical & Electrotherapeutic Apparatus

Headquarters

Sunnyvale, CA

Exchange

Nasdaq

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

Insider	Type	Value	Shares / Price	Date
Chao XingjuanPresident and CEO	Sell	$522K	20,846at $25.03	Sep 15, 2026
Blumberg ScottChief Financial Officer	Sell	$21K	846at $25.00	Sep 15, 2026
Blumberg ScottChief Financial Officer	Sell	$37K	1,521at $24.02	Aug 21, 2026
Woo RaymondChief Technology Officer	Sell	$48K	1,979at $24.02	Aug 21, 2026
Manni Joseph S.Chief Revenue Officer	Sell	$33K	1,361at $24.02	Aug 21, 2026
Foehr DavidSenior VP, Finance and PAO	Sell	$24K	993at $24.02	Aug 21, 2026
Foehr DavidSenior VP, Finance and PAO	Sell	$21K	859at $23.95	Aug 24, 2026
Chao XingjuanPresident and CEO	Sell	$146K	6,068at $24.02	Aug 21, 2026
Blumberg ScottChief Financial Officer	Sell	$25K	990at $25.00	Aug 18, 2026
Blumberg ScottChief Financial Officer	Sell	$839K	33,512at $25.03	Aug 19, 2026
Taylor Joseph MichaelInsider	Sell	$306K	13,095at $23.40	Aug 13, 2026
Chao XingjuanPresident and CEO	Sell	$714K	39,000at $18.32	Aug 3, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for CBLL.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable CBLL activity by email

Free alerts for the insider and congressional trades worth watching.

Email address

US mobile number (optional)

SMS is optional: we only save your number if you check the consent box and provide a valid number. US mobile numbers only.

By checking this box and submitting, I agree to receive recurring automated marketing text messages from MySmarTrend (Ramy LLC) at the mobile number provided, including market alerts, commentary, and offers for MySmarTrend products and subscriptions. Messages may begin when the SMS program launches. Message frequency varies. Message and data rates may apply. Consent is not a condition of purchase or email signup. Reply STOP to opt out or HELP for help once messaging begins. Before launch or at any time, contact privacy@mysmartrend.com to withdraw consent or get help. I agree to the SMS Terms and acknowledge the Privacy Policy.

SMS Terms and Privacy Policy.

By submitting your email address, you will receive a free subscription to the MySmarTrend e-letter, and offers from us and our affiliates that we think might interest you. You can unsubscribe at any time. Privacy Policy.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.